Osaic Holdings’s AIM ImmunoTech AIM Stock Holding History

Osaic Holdings’s Portfolio AIM Stock Details AIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3	Hold	15	–	–	﹤0.01%	7973
2026 Q1	$7	Hold	15	–	–	﹤0.01%	7754
2025 Q4	$16	Hold	15	–	–	﹤0.01%	7748
2025 Q3	$37	Buy	15 +5	+50%	+$22	﹤0.01%	7801
2025 Q2	$86	Hold	10	–	–	﹤0.01%	7578
2025 Q1	$120	Hold	10	–	–	﹤0.01%	7219
2024 Q4	$200	Hold	10	–	–	﹤0.01%	7164
2024 Q3	$270	Hold	10	–	–	﹤0.01%	7127
2024 Q2	$370	Hold	10	–	–	﹤0.01%	7058
2024 Q1	$470	Sell	10 -6	-38%	-$249	﹤0.01%	6837
2023 Q4	$697	Sell	16 -7	-30%	-$326	﹤0.01%	6841
2023 Q3	$1.04K	Hold	23	–	–	﹤0.01%	6810
2023 Q2	$1.52K	Hold	23	–	–	﹤0.01%	6752
2023 Q1	$979	Hold	23	–	–	﹤0.01%	6967
2022 Q4	$71	Sell	23 -2	-8%	-$93	﹤0.01%	7124
2022 Q3	$2K	Hold	25	–	–	﹤0.01%	6911
2022 Q2	$2K	Buy	25 +10	+67%	+$960	﹤0.01%	7001
2022 Q1	$1K	Sell	15 -20	-57%	-$1.72K	﹤0.01%	7192
2021 Q4	$3K	Buy	35 +20	+133%	+$3.09K	﹤0.01%	6971
2021 Q3	$3K	Buy	15 +6	+67%	+$1.21K	﹤0.01%	6815
2021 Q2	$2K	Buy	9 +4	+80%	+$857	﹤0.01%	6805
2021 Q1	$1K	Hold	5	–	–	﹤0.01%	6773
2020 Q4	$1K	Hold	5	–	–	﹤0.01%	6364
2020 Q3	$1K	Hold	5	–	–	﹤0.01%	6169
2020 Q2	$1K	Sell	5 -233	-98%	-$56.6K	﹤0.01%	6072
2020 Q1	$61K	Buy	+238	New	+$37.3K	﹤0.01%	3834

Other funds holding AIM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

GSC

Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Osaic Holdings's AIM Position: Q2 2026 in Review

Osaic Holdings held its AIM ImmunoTech (AIM) position steady in Q2 2026 at 15 shares worth $3. The position accounts for ﹤0.01% of the portfolio, ranked #7973.

Osaic Holdings first reported a position in AIM in Q1 2020 and has held it in 26 quarters since. The position peaked at $61K in Q1 2020. 18 funds tracked by Wall St. Rank hold AIM as of Q2 2026.

Osaic Holdings held 15 shares of AIM ImmunoTech worth $3 as of Q2 2026.
Osaic Holdings left its AIM ImmunoTech share count unchanged in Q2 2026.
AIM ImmunoTech made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7973 holding.
Osaic Holdings first reported a position in AIM ImmunoTech in Q1 2020 and has held it in 26 quarters since.
Osaic Holdings's AIM ImmunoTech position peaked at $61K in Q1 2020.
18 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.